Skip to main content

Advertisement

SpringerLink
Log in

Update of research and management of hepatitis B

  • Review
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. H Okamoto F Tsuda H Sakugawa RI Sastrosoewignjo M Imai Y Miyakawa et al. (1998) ArticleTitleTyping hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes J Gen Virol 69 2575–83

    Google Scholar 

  2. H Norder AM Courouce LO Magnius (1994) ArticleTitleComplete genotypes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes Virology 198 489–503 Occurrence Handle10.1006/viro.1994.1060 Occurrence Handle1:CAS:528:DyaK2cXitlOhsbk%3D Occurrence Handle8291231

    Article  CAS  PubMed  Google Scholar 

  3. L Stuyver S De Grandt C Van Geyt F Zoulin M Fried RF Schinazi et al. (2000) ArticleTitleA new genotype of hepatitis B virus: complete genome and phylogenetic relatedness J Gen Virol 81 67–74 Occurrence Handle1:CAS:528:DC%2BD3cXjvVKrsg%3D%3D Occurrence Handle10640543

    CAS  PubMed  Google Scholar 

  4. P Arauz-Ruiz H Norder BH Robertson LO Magnius (2002) ArticleTitleA new American genotype of hepatitis B virus revealed in Central America J Gen Virol 83 2059–73 Occurrence Handle1:CAS:528:DC%2BD38XlvVCrsLg%3D Occurrence Handle12124470

    CAS  PubMed  Google Scholar 

  5. E Orito T Ichida H Sakugawa M Sata N Horiike K Hino et al. (2001) ArticleTitleGeographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan Hepatology 34 590–4 Occurrence Handle10.1053/jhep.2001.27221 Occurrence Handle1:STN:280:DC%2BD3Mvot1ykug%3D%3D Occurrence Handle11526547

    Article  CAS  PubMed  Google Scholar 

  6. Y Miyakawa M Mizokami (2003) ArticleTitleClassifying hepatitis B Intervirology 46 329–38 Occurrence Handle10.1159/000074988 Occurrence Handle1:CAS:528:DC%2BD3sXhtVSjt7rO Occurrence Handle14688448

    Article  CAS  PubMed  Google Scholar 

  7. F Sugauchi E Orito T Ichida H Kato H Sakugawa S Kakumu et al. (2002) ArticleTitleHepatitis B virus genotype B with or without recombination with genotype C over the precore region plus the core gene J Virol 76 5985–92 Occurrence Handle10.1128/JVI.76.12.5985-5992.2002 Occurrence Handle1:CAS:528:DC%2BD38XktlSqsr8%3D Occurrence Handle12021331

    Article  CAS  PubMed  Google Scholar 

  8. CL Lai RN Chien NW Leung TT Chang R Guan DI Tai et al. (1998) ArticleTitleA one-year trial of lamivudine for chronic hepatitis B: Asian Hepatitis Lamivudine Study Group N Engl J Med 339 61–8 Occurrence Handle10.1056/NEJM199807093390201 Occurrence Handle1:CAS:528:DyaK1cXkvVSqtbY%3D Occurrence Handle9654535

    Article  CAS  PubMed  Google Scholar 

  9. JL Dienstag ER Schiff TL Wright RP Perrillo HW Hann Z Goodman et al. (1999) ArticleTitleLamivudine as initial treatment for chronic hepatitis B in the United States N Engl J Med 341 1256–63 Occurrence Handle10.1056/NEJM199910213411702 Occurrence Handle1:CAS:528:DyaK1MXnt1Cqs78%3D Occurrence Handle10528035

    Article  CAS  PubMed  Google Scholar 

  10. K Chayama Y Suzuki M Kobayashi M Kobayashi A Tsubota M Hashimoto et al. (1998) ArticleTitleEmergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and retakeover by wild type after cessation of therapy Hepatology 27 1711–6 Occurrence Handle10.1002/hep.510270634 Occurrence Handle1:CAS:528:DyaK1cXjvVCrs78%3D Occurrence Handle9620347

    Article  CAS  PubMed  Google Scholar 

  11. P Marcellin TT Chang SG Lim MJ Tong W Sievert ML Shiffman et al. (2003) ArticleTitleAdefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B N Engl J Med 348 808–16 Occurrence Handle10.1056/NEJMoa020681 Occurrence Handle1:CAS:528:DC%2BD3sXhsFKisrc%3D Occurrence Handle12606735

    Article  CAS  PubMed  Google Scholar 

  12. SJ Hadziyannis NC Tassopoulos EJ Heathcote TT Chang G Kitis M Rizzetto et al. (2003) ArticleTitleAdefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B N Engl J Med 348 800–7 Occurrence Handle10.1056/NEJMoa021812 Occurrence Handle1:CAS:528:DC%2BD3sXhsFKju7w%3D Occurrence Handle12606734

    Article  CAS  PubMed  Google Scholar 

  13. C Westland W Delaney Suffix4th H Yang SS Chen P Marcellin S Hadziyannis et al. (2003) ArticleTitleHepatitis B virus genotypes and virological response in 694 patients in phase III studies of adefovir dipivoxil Gastroenterology 125 107–16 Occurrence Handle10.1016/S0016-5085(03)00700-5 Occurrence Handle1:CAS:528:DC%2BD3sXmtVWqtbc%3D Occurrence Handle12851876

    Article  CAS  PubMed  Google Scholar 

  14. HHJ Balfour (1999) ArticleTitleAntiviral drugs N Engl J Med 340 1255–68 Occurrence Handle10.1056/NEJM199904223401608 Occurrence Handle1:CAS:528:DyaK1MXivFWit70%3D Occurrence Handle10210711

    Article  CAS  PubMed  Google Scholar 

  15. RJ Colonno EV Genovesi I Medina L Lamb SK Durham ML Huang et al. (2001) ArticleTitleLong-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in woodchuck model of chronic hepatitis infection J Infect Dis 184 1236–45 Occurrence Handle10.1086/324003 Occurrence Handle1:CAS:528:DC%2BD3MXpt1Whs7g%3D Occurrence Handle11679911

    Article  CAS  PubMed  Google Scholar 

  16. CM Perry B Jarvis (2001) ArticleTitlePeginterferon-alpha 2a (4kDa): a review of its use in the management of chronic hepatitis C Drugs 61 2263–88 Occurrence Handle1:CAS:528:DC%2BD38XnsVWmtA%3D%3D Occurrence Handle11772139

    CAS  PubMed  Google Scholar 

  17. P Glue JW Fang R Rouzier-Panis C Raffanel R Sabo SK Gupta et al. (2000) ArticleTitlePegylated interferon alfa-2b: pharmacokinetics, safety and preliminary efficacy data Clin Pharmacol Ther 68 556–67 Occurrence Handle10.1067/mcp.2000.110973 Occurrence Handle1:CAS:528:DC%2BD3cXovVeru78%3D Occurrence Handle11103758

    Article  CAS  PubMed  Google Scholar 

  18. L Serfaty D Thabut F Zoulim T Andreani O Chazouilleres N Carbonell et al. (2001) ArticleTitleSequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study Hepatology 34 573–7 Occurrence Handle10.1053/jhep.2001.26819 Occurrence Handle1:CAS:528:DC%2BD3MXmvV2kt7g%3D Occurrence Handle11526544

    Article  CAS  PubMed  Google Scholar 

  19. P Marcellin GK Lau F Bonino P Farci S Hadziyannis R Jin et al. (2004) ArticleTitlePeginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B N Engl J Med 351 1206–17 Occurrence Handle10.1056/NEJMoa040431 Occurrence Handle1:CAS:528:DC%2BD2cXns12rsr0%3D Occurrence Handle15371578

    Article  CAS  PubMed  Google Scholar 

  20. GK Lau T Piratvisuth KX Luo P Marcellin S Thongsawat G Cooksley et al. (2005) ArticleTitlePeginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B N Engl J Med 352 2682–95 Occurrence Handle10.1056/NEJMoa043470 Occurrence Handle1:CAS:528:DC%2BD2MXls1SktL8%3D Occurrence Handle15987917

    Article  CAS  PubMed  Google Scholar 

  21. E Orito M Mizokami (2003) ArticleTitleHepatitis B virus genotypes and hepatocellular carcinoma Intervirology 46 408–12 Occurrence Handle10.1159/000075000 Occurrence Handle14688460

    Article  PubMed  Google Scholar 

  22. H Sumi O Yokosuka N Seki M Arai F Imazeki T Kurihara et al. (2003) ArticleTitleInfluence of hepatitis B virus genotypes on the progression of chronic type B liver disease Hepatology 37 19–26 Occurrence Handle10.1053/jhep.2003.50036 Occurrence Handle1:CAS:528:DC%2BD3sXovVWitg%3D%3D Occurrence Handle12500184

    Article  CAS  PubMed  Google Scholar 

  23. E Orito M Mizokami H Sakugawa K Michitaka K Ishikawa T Ichida et al. (2001) ArticleTitleA case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C Hepatology 33 218–23 Occurrence Handle10.1053/jhep.2001.20532 Occurrence Handle1:CAS:528:DC%2BD3MXktFajsA%3D%3D Occurrence Handle11124839

    Article  CAS  PubMed  Google Scholar 

  24. S Usuda H Okamoto H Iwanari K Baba F Tsuda Y Miyakawa et al. (1999) ArticleTitleSerological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product J Virol Methods 80 97–112 Occurrence Handle10.1016/S0166-0934(99)00039-7 Occurrence Handle1:CAS:528:DyaK1MXjsVSht7s%3D Occurrence Handle10403681

    Article  CAS  PubMed  Google Scholar 

  25. S Usuda H Okamoto T Tanaka K Kidd-Ljunggren PV Holland Y Miyakawa et al. (2001) ArticleTitleDifferentiation of hepatitis B virus genotypes D and E by ELISA using monoclonal antibodies to epitopes on the preS2-region product J Virol Methods 87 81–9

    Google Scholar 

  26. H Sakugawa H Nakasone T Nakayoshi E Orito M Mizokami T Yamashiro et al. (2002) ArticleTitlePreponderance of hepatitis B virus genotype B contributes to a better prognosis of chronic HBV infection in Okinawa, Japan J Med Virol 67 484–9 Occurrence Handle10.1002/jmv.10127 Occurrence Handle12115993

    Article  PubMed  Google Scholar 

  27. X Ding M Mizokami G Yao B Xu E Orito R Ueda et al. (2001) ArticleTitleHepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China Intervirology 44 43–7 Occurrence Handle10.1159/000050029 Occurrence Handle1:STN:280:DC%2BD3M3osF2itA%3D%3D Occurrence Handle11223719

    Article  CAS  PubMed  Google Scholar 

  28. JH Kao PJ Chen MY Lai DS Chen (2000) ArticleTitleHepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B Gastroenterology 118 554–9 Occurrence Handle10.1016/S0016-5085(00)70261-7 Occurrence Handle1:STN:280:DC%2BD3c7mslWjug%3D%3D Occurrence Handle10702206

    Article  CAS  PubMed  Google Scholar 

  29. CJ Chu EB Keeffe SH Han RP Perrillo AD Min C Soldevila-Pico et al. (2003) ArticleTitleHepatitis B virus genotypes in the United States: results of a nationwide study Gastroenterology 125 444–51 Occurrence Handle10.1016/S0016-5085(03)00895-3 Occurrence Handle12891547

    Article  PubMed  Google Scholar 

  30. M Lindh C Hannoun AP Dhillon G Norkrans P Horal (1999) ArticleTitleCore promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers J Infect Dis 179 775–82 Occurrence Handle10.1086/314688 Occurrence Handle1:CAS:528:DyaK1MXitlSlsrk%3D Occurrence Handle10068571

    Article  CAS  PubMed  Google Scholar 

  31. CJ Chu M Hussain AS Lok (2002) ArticleTitleHepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C Gastroenterology 122 1756–62 Occurrence Handle10.1053/gast.2002.33588 Occurrence Handle1:CAS:528:DC%2BD38Xlt12gsrc%3D Occurrence Handle12055581

    Article  CAS  PubMed  Google Scholar 

  32. T Nakayoshi T Maeshiro T Nakayoshi H Nakasone H Sakugawa F Kinjo et al. (2003) ArticleTitleDifference in prognosis between patients infected with hepatitis B virus with genotype B and those with genotype C in the Okinawa Islands: a prospective study J Med Virol 70 350–4 Occurrence Handle10.1002/jmv.10270 Occurrence Handle12766996

    Article  PubMed  Google Scholar 

  33. JH Kao PJ Chen MY Lai DS Chen (2004) ArticleTitleHepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers J Med Virol 72 363–9 Occurrence Handle10.1002/jmv.10534 Occurrence Handle1:CAS:528:DC%2BD2cXhvVCjtL8%3D Occurrence Handle14748059

    Article  CAS  PubMed  Google Scholar 

  34. YH Ni MH Chang KJ Wang HY Hsu HL Chen JH Kao et al. (2004) ArticleTitleClinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma Gastroenterology 127 1733–8 Occurrence Handle10.1053/j.gastro.2004.09.048 Occurrence Handle1:CAS:528:DC%2BD2MXit1Gjtw%3D%3D Occurrence Handle15578511

    Article  CAS  PubMed  Google Scholar 

  35. V Thakur RC Guptan SN Kazim V Malhortra SK Sarin (2002) ArticleTitleProfile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent J Gastroenterol Hepatol 17 165–70 Occurrence Handle10.1046/j.1440-1746.2002.02605.x Occurrence Handle11966946

    Article  PubMed  Google Scholar 

  36. C Mayerat A Mantegani PC Frei (1999) ArticleTitleDoes hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J Viral Hepatol 6 299–304 Occurrence Handle10.1046/j.1365-2893.1999.00174.x Occurrence Handle1:STN:280:DC%2BD3c%2FnsFahsA%3D%3D

    Article  CAS  Google Scholar 

  37. K Kikuchi H Niitsuma M Ishii JG Cervantes S Hong T Ojima et al. (2000) ArticleTitleGenoepidemiology and its relationship to clinical features in patients infected chronically with hepatitis B virus (HBV) Hepatol Res 17 43–55

    Google Scholar 

  38. M Kobayashi Y Arase K Ikeda A Tsubota Y Suzuki S Saitoh et al. (2002) ArticleTitleClinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C J Gastroenterol 37 35–9 Occurrence Handle10.1007/s535-002-8130-z Occurrence Handle11824798

    Article  PubMed  Google Scholar 

  39. M Kobayashi Y Arase K Ikeda A Tsubota Y Suzuki T Hosaka et al. (2003) ArticleTitleClinical features of hepatitis B virus genotype A in Japanese patients J Gastroenterol 38 656–62 Occurrence Handle10.1007/s00535-003-1118-7 Occurrence Handle12898358

    Article  PubMed  Google Scholar 

  40. M Kobayashi F Suzuki Y Arase N Akuta Y Suzuki T Hosaka et al. (2004) ArticleTitleInfection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001 J Gastroenterol 39 844–50 Occurrence Handle15565403

    PubMed  Google Scholar 

  41. WF Carman MR Jacyna S Hadziyannis P Karayiannis MJ McGarvey A Makris et al. (1989) ArticleTitleMutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection Lancet 2 588–91 Occurrence Handle1:STN:280:BiaA28znvFU%3D Occurrence Handle2570285

    CAS  PubMed  Google Scholar 

  42. JS Li SP Tong YM Wen L Vitvitski Q Zhang C Trepo (1993) ArticleTitleHepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region J Virol 67 5402–10 Occurrence Handle1:CAS:528:DyaK3sXmsVGgurg%3D Occurrence Handle8350403

    CAS  PubMed  Google Scholar 

  43. AS Lok U Akarca S Greene (1994) ArticleTitleMutations in the precore region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal Proc Natl Acad Sci USA 91 4077–81 Occurrence Handle1:CAS:528:DyaK2cXktVamtbg%3D Occurrence Handle8171038

    CAS  PubMed  Google Scholar 

  44. VE Buckwold Z Xu M Chen TS Yen JH Ou (1996) ArticleTitleEffects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication J Virol 70 5845–51 Occurrence Handle1:CAS:528:DyaK28XkvFGhs70%3D Occurrence Handle8709203

    CAS  PubMed  Google Scholar 

  45. PP Scaglioni M Melegari JR Wands (1997) ArticleTitleBiologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame Virology 233 374–81 Occurrence Handle10.1006/viro.1997.8594 Occurrence Handle1:CAS:528:DyaK2sXksVClu7k%3D Occurrence Handle9217060

    Article  CAS  PubMed  Google Scholar 

  46. X Yu JE Mertz (2003) ArticleTitleDistinct modes of regulation of transcription of hepatitis B virus by the nuclear receptors HNF4alpha and COUP-TF1 J Virol 77 2489–99 Occurrence Handle1:CAS:528:DC%2BD3sXpvVGnuw%3D%3D Occurrence Handle12551987

    CAS  PubMed  Google Scholar 

  47. S Gunther N Piwon H Will (1998) ArticleTitleWild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) → T, A(1762) → T and G(1764) → A mutations in the core promoter J Gen Virol 79 375–80 Occurrence Handle1:CAS:528:DyaK1cXotVOgsQ%3D%3D Occurrence Handle9472623

    CAS  PubMed  Google Scholar 

  48. H Tang AK Raney A Mclachlan (2001) ArticleTitleReplication of the wild type and a natural hepatitis B virus nucleocapsid promoter variant is differentially regulated by nuclear hormone receptors in cell culture J Virol 75 8937–48 Occurrence Handle1:CAS:528:DC%2BD3MXntVGrtb0%3D Occurrence Handle11533157

    CAS  PubMed  Google Scholar 

  49. K Shiraki N Yoshihara M Sakurai T Eto T Kawana (1980) ArticleTitleAcute hepatitis B in infants born to carrier mother with the antibody to hepatitis B e antigen J Pediatr 97 768–70 Occurrence Handle1:STN:280:Bi6D2cfpsl0%3D Occurrence Handle7431166

    CAS  PubMed  Google Scholar 

  50. S Terazawa M Kojima T Yamanaka S Yotsumoto H Okamoto F Tsuda et al. (1991) ArticleTitleHepatitis B virus mutants with precore-region defects in two babies with fulminant hepatitis and their mothers positive for antibody to hepatitis B e antigen Pediatr Res 29 5–9 Occurrence Handle1:STN:280:By6C2MnjvFY%3D Occurrence Handle2000259

    CAS  PubMed  Google Scholar 

  51. HL Chen CJ Chang MS Kong FC Huang HC Lee CC Lin et al. (2004) ArticleTitlePediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination Hepatology 39 58–63 Occurrence Handle14752823

    PubMed  Google Scholar 

  52. EA Fagan PM Smith F Davison R Williams (1986) ArticleTitleFulminant hepatitis B in successive female sexual partners of two anti-HBe-positive males Lancet 2 538–40 Occurrence Handle1:STN:280:BimA3cbotVA%3D Occurrence Handle2875281

    CAS  PubMed  Google Scholar 

  53. WF Carman EA Fagan S Hadziyannis P Karayiannis NC Tassopoulos R Williams HC Thomas (1991) ArticleTitleAssociation of a precore genomic variant of hepatitis B virus with fulminant hepatitis Hepatology 14 219–22 Occurrence Handle10.1016/0270-9139(91)91406-Q Occurrence Handle1:STN:280:By6A3MjkvFY%3D Occurrence Handle1860679

    Article  CAS  PubMed  Google Scholar 

  54. S Sato K Suzuki Y Akahane K Akamatsu K Akiyama K Yunomura et al. (1995) ArticleTitleHepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis Ann Intern Med 122 241–8 Occurrence Handle1:CAS:528:DyaK2MXksFejtbc%3D Occurrence Handle7825758

    CAS  PubMed  Google Scholar 

  55. Y Kosaka K Takase M Kojima M Shimizu K Inoue M Yoshiba et al. (1991) ArticleTitleFulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen Gastroenterology 100 1087–94 Occurrence Handle1:STN:280:By6C28%2FovFY%3D Occurrence Handle2001807

    CAS  PubMed  Google Scholar 

  56. M Omata T Ehata O Yokosuka K Hosoda M Ohto (1991) ArticleTitleMutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis N Engl J Med 324 1699–704 Occurrence Handle1:STN:280:By6B3sfptFQ%3D Occurrence Handle2034246

    CAS  PubMed  Google Scholar 

  57. TJ Liang K Hasegawa N Rimon JR Wands E Ben-Porath (1991) ArticleTitleA hepatitis B virus mutant associated with an epidemic of fulminant hepatitis N Engl J Med 324 1705–9 Occurrence Handle1:STN:280:By6B3sfptFU%3D Occurrence Handle2034247

    CAS  PubMed  Google Scholar 

  58. TJ Liang K Hasegawa SJ Munoz CN Shapiro B Yoffe BJ McMahon et al. (1994) ArticleTitleHepatitis B virus precore mutation and fulminant hepatitis in the United States: a polymerase chain reaction-based assay for the detection of specific mutation J Clin Invest 93 550–5 Occurrence Handle1:CAS:528:DyaK2cXkslClu7Y%3D Occurrence Handle8113393

    CAS  PubMed  Google Scholar 

  59. MT Chen JN Billaud M Sallberg LG Guidotti FV Chisari J Jones et al. (2004) ArticleTitleA function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen Proc Natl Acad Sci USA 101 14913–8 Occurrence Handle1:CAS:528:DC%2BD2cXovVyis70%3D Occurrence Handle15469922

    CAS  PubMed  Google Scholar 

  60. D Milich TJ Liang (2003) ArticleTitleExploring the biological basis of hepatitis B e antigen in hepatitis B virus infection Hepatology 38 1075–86 Occurrence Handle10.1053/jhep.2003.50453 Occurrence Handle1:CAS:528:DC%2BD3sXpsVOnsbk%3D Occurrence Handle14578844

    Article  CAS  PubMed  Google Scholar 

  61. ZL Fang R Ling SS Wang J Nong CS Huang TJ Harrison (1998) ArticleTitleHBV core promoter mutations prevail in patients with hepatocellular carcinoma from Guangxi, China J Med Virol 56 18–24 Occurrence Handle10.1002/(SICI)1096-9071(199809)56:1<18::AID-JMV4>3.0.CO;2-Q Occurrence Handle1:CAS:528:DyaK1cXlsVSgsLo%3D Occurrence Handle9700628

    Article  CAS  PubMed  Google Scholar 

  62. M Baptista A Kramvis MC Kew (1999) ArticleTitleHigh prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers Hepatology 29 946–53 Occurrence Handle10.1002/hep.510290336 Occurrence Handle1:CAS:528:DyaK1MXhvFyjsLc%3D Occurrence Handle10051502

    Article  CAS  PubMed  Google Scholar 

  63. CC Hsia H Yuwen E Tabor (1996) ArticleTitleHot-spot mutations in hepatitis B virus X gene in hepatocellular carcinoma Lancet 348 625–6 Occurrence Handle10.1016/S0140-6736(05)64851-9 Occurrence Handle1:STN:280:BymA2s%2FntFE%3D Occurrence Handle8774611

    Article  CAS  PubMed  Google Scholar 

  64. JH Kao PJ Chen MY Lai DS Chen (2003) ArticleTitleBasal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma Gastroenterology 124 327–34 Occurrence Handle10.1053/gast.2003.50053 Occurrence Handle1:CAS:528:DC%2BD3sXhsFOhtbk%3D Occurrence Handle12557138

    Article  CAS  PubMed  Google Scholar 

  65. SY Kuang PE Jackson JB Wang PX Lu A Munoz GS Qian et al. (2004) ArticleTitleSpecific mutations of hepatitis B virus in plasma predict liver cancer development Proc Natl Acad Sci USA 101 3575–80 Occurrence Handle10.1073/pnas.0308232100 Occurrence Handle1:CAS:528:DC%2BD2cXisFWmtrc%3D Occurrence Handle14990795

    Article  CAS  PubMed  Google Scholar 

  66. CT Yeh CH Shen DI Tai CM Chu YF Liaw (2000) ArticleTitleIdentification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma Oncogene 19 5213–20 Occurrence Handle1:CAS:528:DC%2BD3cXosVOisbY%3D Occurrence Handle11077437

    CAS  PubMed  Google Scholar 

  67. WF Carman AR Zanetti P Karayiannis J Waters G Manzillo E Tanzi et al. (1990) ArticleTitleVaccine-induced escape mutant of hepatitis B virus Lancet 336 325–9 Occurrence Handle10.1016/0140-6736(90)91874-A Occurrence Handle1:STN:280:By%2BA283pslI%3D Occurrence Handle1697396

    Article  CAS  PubMed  Google Scholar 

  68. G Gerken D Kremsdorf F Capel MA Petit C Dauguet MP Manns et al. (1991) ArticleTitleHepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection Virology 183 555–65 Occurrence Handle10.1016/0042-6822(91)90984-J Occurrence Handle1:CAS:528:DyaK3MXltVOhu7Y%3D Occurrence Handle1853561

    Article  CAS  PubMed  Google Scholar 

  69. M Minami T Okanoue E Nakajima K Yasui K Kagawa K Kashima (1993) ArticleTitleSignificance of pre-S region-defective hepatitis B virus that emerged during exacerbation of chronic type B hepatitis Hepatology 17 558–63 Occurrence Handle1:STN:280:ByyB3sbhtVc%3D Occurrence Handle8477960

    CAS  PubMed  Google Scholar 

  70. M Takayanagi S Kakumu T Ishikawa Y Higashi K Yoshioka T Wakita (1993) ArticleTitleComparison of envelope and precore/core variants of hepatitis B virus (HBV) during chronic HBV infection Virology 196 138–45 Occurrence Handle10.1006/viro.1993.1462 Occurrence Handle1:CAS:528:DyaK3sXms1Orsb8%3D Occurrence Handle8356791

    Article  CAS  PubMed  Google Scholar 

  71. E Nakajima M Minami T Ochiya K Kagawa T Okanoue (1994) ArticleTitlePreS1 deleted variants of hepatitis B virus in patients with chronic hepatitis J Hepatol 20 329–35 Occurrence Handle10.1016/S0168-8278(94)80003-0 Occurrence Handle1:CAS:528:DyaK2cXmslOrsrY%3D Occurrence Handle7516949

    Article  CAS  PubMed  Google Scholar 

  72. M Melegari S Bruno JR Wands (1994) ArticleTitleProperties of hepatitis B virus pre-S1 deletion mutants Virology 199 292–300 Occurrence Handle10.1006/viro.1994.1127 Occurrence Handle1:CAS:528:DyaK2cXhvVymt74%3D Occurrence Handle8122362

    Article  CAS  PubMed  Google Scholar 

  73. M Melegari PP Scaglioni JR Wands (1997) ArticleTitleThe small envelope protein is required for secretion of a naturally occurring hepatitis B virus mutant with pre-S1 deleted J Virol 71 5449–54 Occurrence Handle1:CAS:528:DyaK2sXjvVKls7Y%3D Occurrence Handle9188617

    CAS  PubMed  Google Scholar 

  74. HC Wang WT Chang WW Chang HC Wu W Huang HY Lei et al. (2005) ArticleTitleHepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes Hepatology 41 761–70 Occurrence Handle1:CAS:528:DC%2BD2MXjsV2msLo%3D Occurrence Handle15726643

    CAS  PubMed  Google Scholar 

  75. M Hass C Hannoun T Kalinina G Sommer C Manegold S Gunther (2005) ArticleTitleFunctional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals Hepatology 42 93–103 Occurrence Handle10.1002/hep.20748 Occurrence Handle1:CAS:528:DC%2BD2MXms12ntr4%3D Occurrence Handle15962285

    Article  CAS  PubMed  Google Scholar 

  76. RP Beasley LY Hwang CC Lin CS Chien (1981) ArticleTitleHepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan Lancet 2 1129–33 Occurrence Handle1:STN:280:Bi2D2sblslA%3D Occurrence Handle6118576

    CAS  PubMed  Google Scholar 

  77. MW Yu HC Chang YF Liaw SM Lin SD Lee CJ Liu et al. (2000) ArticleTitleFamilial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives J Natl Cancer Inst 92 1159–64 Occurrence Handle1:STN:280:DC%2BD3cvlvFensg%3D%3D Occurrence Handle10904089

    CAS  PubMed  Google Scholar 

  78. P Arbuthnot M Kew (2001) ArticleTitleHepatitis B virus and hepatocellular carcinoma Int J Exp Pathol 82 77–100 Occurrence Handle10.1111/j.1365-2613.2001.iep178.x Occurrence Handle1:CAS:528:DC%2BD3MXmtVymu7s%3D Occurrence Handle11454100

    Article  CAS  PubMed  Google Scholar 

  79. C Brechot (2004) ArticleTitlePathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms Gastroenterology 127 S56–61 Occurrence Handle10.1053/j.gastro.2004.09.016 Occurrence Handle1:CAS:528:DC%2BD2cXhtVGmtb7E Occurrence Handle15508104

    Article  CAS  PubMed  Google Scholar 

  80. MJ Bouchard RJ Schneider (2004) ArticleTitleThe enigmatic X gene of hepatitis B virus J Virol 78 12725–34 Occurrence Handle10.1128/JVI.78.23.12725-12734.2004 Occurrence Handle1:CAS:528:DC%2BD2cXhtVaqtbrL Occurrence Handle15542625

    Article  CAS  PubMed  Google Scholar 

  81. D Ganem RJ Schneider (2001) Hepadnaviridae: the viruses and their replication DM Knipe PM Howley (Eds) Fields' virology EditionNumberVol 2, 4th edn. Lippincott Williams & Wilkins Philadelphia 2923–69

    Google Scholar 

  82. CM Kim K Koike I Saito T Miyamura GH Jay (1991) ArticleTitleBx gene of hepatitis B virus induces liver cancer in transgenic mice Nature 351 317–20 Occurrence Handle1:CAS:528:DyaK3MXkt1Kqsbw%3D Occurrence Handle2034275

    CAS  PubMed  Google Scholar 

  83. MY Cha CM Kim YM Park WS Ryu (2004) ArticleTitleHepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells Hepatology 39 1683–93 Occurrence Handle10.1002/hep.20245 Occurrence Handle1:CAS:528:DC%2BD2cXlsVWrtrY%3D Occurrence Handle15185310

    Article  CAS  PubMed  Google Scholar 

  84. H Sirma C Giannini K Poussin P Paterlini D Kremsdorf C Brechot (1999) ArticleTitleHepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx Oncogene 18 4848–59 Occurrence Handle10.1038/sj.onc.1202867 Occurrence Handle1:CAS:528:DyaK1MXlvFyns74%3D Occurrence Handle10490818

    Article  CAS  PubMed  Google Scholar 

  85. H Tu C Bonura C Giannini H Mouly P Soussan M Kew et al. (2001) ArticleTitleBiological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues Cancer Res 61 7803–10 Occurrence Handle1:CAS:528:DC%2BD3MXotlakurk%3D Occurrence Handle11691796

    CAS  PubMed  Google Scholar 

  86. FV Chisari K Klopchin T Moriyama C Pasquinelli HA Dunsford S Sell et al. (1989) ArticleTitleMolecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice Cell 59 1145–56 Occurrence Handle10.1016/0092-8674(89)90770-8 Occurrence Handle1:CAS:528:DyaK3cXhtlKlurc%3D Occurrence Handle2598264

    Article  CAS  PubMed  Google Scholar 

  87. A Dejean L Bougueleret KH Grzeschik P Tiollais (1986) ArticleTitleHepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma Nature 322 70–2 Occurrence Handle1:CAS:528:DyaL28XkslelurY%3D Occurrence Handle3014347

    CAS  PubMed  Google Scholar 

  88. J Wang X Chenivesse B Henglein C Brechot (1990) ArticleTitleHepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma Nature 343 555–7 Occurrence Handle10.1038/343555a0 Occurrence Handle1:CAS:528:DyaK3cXksFens7o%3D Occurrence Handle1967822

    Article  CAS  PubMed  Google Scholar 

  89. T Tokino K Matsubara (1991) ArticleTitleChromosomal sites for hepatitis B virus integration in human hepatocellular carcinoma J Virol 65 6761–4 Occurrence Handle1:CAS:528:DyaK38XjvVygsQ%3D%3D Occurrence Handle1682510

    CAS  PubMed  Google Scholar 

  90. T Suzuki H Shen K Akagi HC Morse JD Malley DQ Naiman et al. (2002) ArticleTitleNew genes involved in cancer identified by retroviral tagging Nat Genet 32 166–74 Occurrence Handle10.1038/ng949 Occurrence Handle1:CAS:528:DC%2BD38Xms1ajs7g%3D Occurrence Handle12185365

    Article  CAS  PubMed  Google Scholar 

  91. H Shen T Suzuki DJ Munroe C Stewart L Rasmussen DJ Gilbert et al. (2003) ArticleTitleCommon sites of retroviral integration in mouse hematopoietic tumors identified by high-throughput, single nucleotide polymorphism-based mapping and bacterial artificial chromosome hybridization J Virol 77 1584–8 Occurrence Handle1:CAS:528:DC%2BD3sXitl2ktg%3D%3D Occurrence Handle12502872

    CAS  PubMed  Google Scholar 

  92. DR Broussard MM Lozano JP Dudley (2004) ArticleTitleRorgamma (Rorc) is a common integration site in type B leukemogenic virus-induced T-cell lymphomas J Virol 78 4943–6 Occurrence Handle10.1128/JVI.78.9.4943-4946.2004 Occurrence Handle1:CAS:528:DC%2BD2cXjsVKitrk%3D Occurrence Handle15078980

    Article  CAS  PubMed  Google Scholar 

  93. C Cousens JV Bishop AW Philbey CA Gill M Palmarini JO Carlson et al. (2004) ArticleTitleAnalysis of integration sites of Jaagsiekte sheep retrovirus in ovine pulmonary adenocarcinoma J Virol 78 8506–12 Occurrence Handle10.1128/JVI.78.16.8506-8512.2004 Occurrence Handle1:CAS:528:DC%2BD2cXmslSntbk%3D Occurrence Handle15280459

    Article  CAS  PubMed  Google Scholar 

  94. O Kustikova B Fehse U Modlich M Yang J Dullmann K Kamino et al. (2005) ArticleTitleClonal dominance of hematopoietic stem cells triggered by retroviral gene marking Science 308 1171–4 Occurrence Handle10.1126/science.1105063 Occurrence Handle1:CAS:528:DC%2BD2MXkt1Slsbk%3D Occurrence Handle15905401

    Article  CAS  PubMed  Google Scholar 

  95. LS Collier CM Carlson S Ravimohan AJ Dupuy DA Largaespada (2005) ArticleTitleCancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse Nature 436 272–6 Occurrence Handle10.1038/nature03681 Occurrence Handle1:CAS:528:DC%2BD2MXmtVersr4%3D Occurrence Handle16015333

    Article  CAS  PubMed  Google Scholar 

  96. S Hacein-Bey-Abina C Von Kalle M Schmidt MP McCormack N Wulffraat P Leboulch et al. (2003) ArticleTitleLMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 Science 302 415–9 Occurrence Handle10.1126/science.1088547 Occurrence Handle1:CAS:528:DC%2BD3sXotV2isb4%3D Occurrence Handle14564000

    Article  CAS  PubMed  Google Scholar 

  97. M Minami K Poussin C Brechot P Paterlini (1995) ArticleTitleA novel PCR technique using Alu-specific primers to identify unknown flanking sequences from the human genome Genomics 29 403–8 Occurrence Handle1:CAS:528:DyaK2MXovVSlsLg%3D Occurrence Handle8666388

    CAS  PubMed  Google Scholar 

  98. D Gozuacik Y Murakami K Saigo M Chami C Mugnier D Lagorce et al. (2001) ArticleTitleIdentification of human cancer-related genes by naturally occurring hepatitis B virus DNA tagging Oncogene 20 6233–40 Occurrence Handle10.1038/sj.onc.1204835 Occurrence Handle1:CAS:528:DC%2BD3MXnsFOiu7g%3D Occurrence Handle11593432

    Article  CAS  PubMed  Google Scholar 

  99. P Paterlini-Brechot K Saigo Y Murakami M Chami D Gozuacik C Mugnier et al. (2003) ArticleTitleHepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene Oncogene 22 3911–6 Occurrence Handle1:CAS:528:DC%2BD3sXks1Cnsbw%3D Occurrence Handle12813464

    CAS  PubMed  Google Scholar 

  100. I Horikawa JC Barrett (2001) ArticleTitlecis-Activation of the human telomerase gene (hTERT) by the hepatitis B virus genome J Natl Cancer Inst 93 117–3 Occurrence Handle10.1093/jnci/93.15.1171

    Article  Google Scholar 

  101. MJ Ferber DP Montoya C Yu I Aderca A McGee EC Thorland et al. (2003) ArticleTitleIntegrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers Oncogene 22 3813–20 Occurrence Handle1:CAS:528:DC%2BD3sXksV2jur8%3D Occurrence Handle12802289

    CAS  PubMed  Google Scholar 

  102. Y Murakami K Saigo H Takashima M Minami T Okanoue C Brechot et al. (2005) ArticleTitleLarge scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas Gut 54 1162–8 Occurrence Handle10.1136/gut.2004.054452 Occurrence Handle1:CAS:528:DC%2BD2MXpt1ersrc%3D Occurrence Handle16009689

    Article  CAS  PubMed  Google Scholar 

  103. A Tamori Y Yamanishi S Kawashima M Kanehisa M Enomoto H Tanaka et al. (2005) ArticleTitleAlteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA Clin Cancer Res 11 5821–6 Occurrence Handle10.1158/1078-0432.CCR-04-2055 Occurrence Handle1:CAS:528:DC%2BD2MXos1CjtL0%3D Occurrence Handle16115921

    Article  CAS  PubMed  Google Scholar 

  104. J Wang F Zindy X Chenivesse E Lamas B Henglein C Brechot (1992) ArticleTitleModification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma Oncogene 7 1653–6 Occurrence Handle1:CAS:528:DyaK2cXlvVKk Occurrence Handle1321406

    CAS  PubMed  Google Scholar 

  105. H De The A Marchio P Tiollais A Dejean (1987) ArticleTitleA novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma Nature 330 667–70 Occurrence Handle1:CAS:528:DyaL1cXhvVWiur4%3D Occurrence Handle2825037

    CAS  PubMed  Google Scholar 

  106. Y Murakami M Minami Y Daimon T Okanoue (2004) ArticleTitleHepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen J Med Virol 72 203–14 Occurrence Handle10.1002/jmv.10547 Occurrence Handle14695661

    Article  PubMed  Google Scholar 

  107. M Minami Y Daimon K Mori H Takashima T Nakajima Y Itoh et al. (2005) ArticleTitleHepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis Oncogene 24 4340–8 Occurrence Handle10.1038/sj.onc.1208628 Occurrence Handle1:CAS:528:DC%2BD2MXlsVWmt78%3D Occurrence Handle15806150

    Article  CAS  PubMed  Google Scholar 

  108. O Yokosuka M Omata F Imazeki K Okuda J Summers (1985) ArticleTitleChanges of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA Hepatology 5 728–34 Occurrence Handle1:STN:280:BiqB1cjgsFc%3D Occurrence Handle4029888

    CAS  PubMed  Google Scholar 

  109. R Guan (2000) ArticleTitleInterferon monotherapy in chronic hepatitis B J Gastroenterol Hepatol 15 IssueIDSuppl E34–40 Occurrence Handle10.1046/j.1440-1746.2000.02101.x Occurrence Handle1:CAS:528:DC%2BD3cXltFOjsbo%3D Occurrence Handle10921380

    Article  CAS  PubMed  Google Scholar 

  110. DK Wong AM Cheung K O'Rourke CD Naylor AS Detsky J Heathcote (1999) ArticleTitleEffect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: a meta analysis Ann Intern Med 119 312–23

    Google Scholar 

  111. HL Janssen G Gerken V Carreno P Marcellin NV Naoumov A Craxi et al. (1999) ArticleTitleInterferon alpha for chronic hepatitis B infection: increased efficacy of prolonged treatment: the European Concerted Action on Viral Hepatitis (EUROHEP) Hepatology 30 238–43 Occurrence Handle10.1002/hep.510300113 Occurrence Handle1:CAS:528:DyaK1MXksVOqsbs%3D Occurrence Handle10385662

    Article  CAS  PubMed  Google Scholar 

  112. YF Liaw SM Lin TJ Chen RN Chien IS Sheen CM Chu (1994) ArticleTitleBeneficial effect of prednisolone withdrawal followed by lymphoblastoid interferon on the treatment of chronic hepatitis B in Asians: a randomized controlled trial J Hepatol 20 175–80 Occurrence Handle10.1016/S0168-8278(05)80055-8 Occurrence Handle1:STN:280:ByuB2srhtlU%3D Occurrence Handle8006397

    Article  CAS  PubMed  Google Scholar 

  113. N Akuta F Suzuki A Tsubota Y Arase Y Suzuki T Someya et al. (2002) ArticleTitleLong-term clinical remission induced by corticosteroid withdrawal therapy (CSWT) in patients with chronic hepatitis B infection: a randomized controlled trial-CSWT with and without follow-up interferon alpha therapy Dig Dis Sci 47 405–14 Occurrence Handle10.1023/A:1013742727165 Occurrence Handle1:CAS:528:DC%2BD38XitVSgsb0%3D Occurrence Handle11855559

    Article  CAS  PubMed  Google Scholar 

  114. SM Lin IS Sheen RN Chien CM Chu YF Liaw (1999) ArticleTitleLong-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection Hepatology 29 971–5 Occurrence Handle10.1002/hep.510290312 Occurrence Handle1:CAS:528:DyaK1MXhvFyjsb8%3D Occurrence Handle10051505

    Article  CAS  PubMed  Google Scholar 

  115. EK Manesis SJ Hadziyannis (2001) ArticleTitleInterferon alpha treatment and retreatment of hepatitis B e antigen negative chronic hepatitis B mutants Gastroenterology 121 101–9 Occurrence Handle10.1053/gast.2001.25524 Occurrence Handle1:CAS:528:DC%2BD3MXlt1ykt7o%3D Occurrence Handle11438498

    Article  CAS  PubMed  Google Scholar 

  116. P Lampertico E Del Ninno A Manzin MF Donato MG Rumi G Lunghi et al. (1997) ArticleTitleA randomized controlled trial of a 24-month course o interferon alpha 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum Hepatology 26 1621–35 Occurrence Handle1:CAS:528:DyaK1cXnsFKj Occurrence Handle9398007

    CAS  PubMed  Google Scholar 

  117. GV Papatheododdis E Manesis SJ Hadziyannis (2001) ArticleTitleThe long term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B J Hepatol 34 306–13

    Google Scholar 

  118. MR Brunetto F Oliveri B Coco G Leandro P Colombatto JM Gorin et al. (2002) ArticleTitleThe outcome of chronic anti-HBe positive chronic hepatitis B in alpha interferon treated and untreated patients: a long term cohort study J Hepatol 36 263–70 Occurrence Handle10.1016/S0168-8278(01)00266-5 Occurrence Handle1:CAS:528:DC%2BD38Xit1eis7s%3D Occurrence Handle11830339

    Article  CAS  PubMed  Google Scholar 

  119. C Niederau T Heintges S Lange G Goldmann CM Niederau L Mohr et al. (1996) ArticleTitleLong-term follow-up of HBeAg-positive patients treated with interferon alpha for chronic hepatitis B N Engl J Med 334 1422–7 Occurrence Handle10.1056/NEJM199605303342202 Occurrence Handle1:STN:280:BymB3Mfot1E%3D Occurrence Handle8618580

    Article  CAS  PubMed  Google Scholar 

  120. SM Lin DI Tai RN Chien IS Sheen CM Chu YF Liaw (2004) ArticleTitleComparison of long-term effects of lymphoblastoid interferon alpha and recombinant interferon alpha-2a therapy in patients with chronic hepatitis B J Viral Hepatol 11 349–57 Occurrence Handle10.1111/j.1365-2893.2004.00512.x

    Article  Google Scholar 

  121. M Van Zonneveld P Honkoop BE Hansen HG Niesters SD Murad RA de Man et al. (2004) ArticleTitleLong-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B Hepatology 39 804–10 Occurrence Handle10.1002/hep.20128 Occurrence Handle1:CAS:528:DC%2BD2cXjtlaiu70%3D Occurrence Handle14999700

    Article  CAS  PubMed  Google Scholar 

  122. K Ikeda S Saitoh Y Suzuki M Kobayashi A Tsubota M Fukuda et al. (1998) ArticleTitleInterferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus Cancer 82 827–35 Occurrence Handle1:CAS:528:DyaK1cXhsVCrtrw%3D Occurrence Handle9486570

    CAS  PubMed  Google Scholar 

  123. R Munoz G Castellano I Fernandez MV Alvarez ML Manzano MS Marcos et al. (2002) ArticleTitleA pilot study of beta-interferon for treatment of patients with chronic hepatitis B who failed to respond to alpha-interferon J Hepatol 37 655–9 Occurrence Handle1:CAS:528:DC%2BD38XotVKktLo%3D Occurrence Handle12399233

    CAS  PubMed  Google Scholar 

  124. WG Cooksley T Piratvisuth SD Lee V Mahachai YC Chao T Tanwandee et al. (2003) ArticleTitlePeginterferon alpha-2a (4kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B J Viral Hepatol 10 298–305 Occurrence Handle10.1046/j.1365-2893.2003.00450.x Occurrence Handle1:STN:280:DC%2BD3szksVOquw%3D%3D

    Article  CAS  Google Scholar 

  125. HL Janssen M van Zonneveld H Senturk S Zeuzem US Akarca Y Cakaloglu et al. (2005) ArticleTitlePeglyated interferon alpha-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomized trial Lancet 365 123–9 Occurrence Handle10.1016/S0140-6736(05)17701-0 Occurrence Handle1:CAS:528:DC%2BD2MXhvF2gsQ%3D%3D Occurrence Handle15639293

    Article  CAS  PubMed  Google Scholar 

  126. JL Dienstag RP Perrillo ER Schiff M Bartholomew C Vicary M Rubin (1995) ArticleTitleA preliminary trial of lamivudine for chronic hepatitis B infection N Engl J Med 333 1657–61 Occurrence Handle10.1056/NEJM199512213332501 Occurrence Handle1:CAS:528:DyaK28XkvFyqtw%3D%3D Occurrence Handle7477217

    Article  CAS  PubMed  Google Scholar 

  127. F Nevens J Main P Honkoop DL Tyrrell J Barber MT Sullivan et al. (1997) ArticleTitleLamivudine therapy for chronic hepatitis B: six month dose-ranging study Gastroenterology 113 1258–63 Occurrence Handle10.1053/gast.1997.v113.pm9322520 Occurrence Handle1:CAS:528:DyaK2sXmslOlsbo%3D Occurrence Handle9322520

    Article  CAS  PubMed  Google Scholar 

  128. YF Liaw NW Leung TT Chang R Guan DI Tai KY Ng et al. (2000) ArticleTitleEffects of extended lamivudine therapy in Asian patients with chronic hepatitis B Gastroenterology 119 172–80 Occurrence Handle10.1053/gast.2000.8559 Occurrence Handle1:CAS:528:DC%2BD3cXlsFGltLs%3D Occurrence Handle10889166

    Article  CAS  PubMed  Google Scholar 

  129. GB Yao ZY Cui BE Wang JL Yao MD Zeng (2004) ArticleTitleA 3-year clinical trial of lamivudine in treatment of patients with chronic hepatitis B Hepatobiliary Pancreat Dis Int 3 188–93 Occurrence Handle1:CAS:528:DC%2BD2cXkvF2ju7w%3D Occurrence Handle15138107

    CAS  PubMed  Google Scholar 

  130. BC Song DJ Suh HC Lee YH Chung YS Lee (2000) ArticleTitleHepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea Hepatology 32 803–6 Occurrence Handle10.1053/jhep.2000.16665 Occurrence Handle1:CAS:528:DC%2BD3cXnslemsbg%3D Occurrence Handle11003626

    Article  CAS  PubMed  Google Scholar 

  131. RN Chien YF Liaw M Atkins (1999) ArticleTitlePretherapy alanine aminotransferase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B Hepatology 30 770–4 Occurrence Handle10.1002/hep.510300313 Occurrence Handle1:CAS:528:DyaK1MXmtVSkt7Y%3D Occurrence Handle10462384

    Article  CAS  PubMed  Google Scholar 

  132. JL Dienstag RD Goldin EJ Heathcote HW Hann M Woessner SL Stephenson et al. (2003) ArticleTitleHistological outcome during long-term lamivudine therapy Gastroenterology 124 105–17 Occurrence Handle10.1053/gast.2003.50013 Occurrence Handle1:CAS:528:DC%2BD3sXot1antQ%3D%3D Occurrence Handle12512035

    Article  CAS  PubMed  Google Scholar 

  133. NC Tassopoulos R Volpes G Pastore J Heathcote M Buti RD Goldin et al. (1999) ArticleTitleEfficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B Hepatology 29 889–96 Occurrence Handle10.1002/hep.510290321 Occurrence Handle1:CAS:528:DyaK1MXhvFyjsLs%3D Occurrence Handle10051494

    Article  CAS  PubMed  Google Scholar 

  134. M Rizzetto NC Tassopoulos RD Goldin R Esteban T Santantonio EJ Heathcote et al. (2005) ArticleTitleExtended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B J Hepatol 42 173–9 Occurrence Handle1:CAS:528:DC%2BD2MXmvFSqtw%3D%3D Occurrence Handle15664241

    CAS  PubMed  Google Scholar 

  135. TT Chang CL Lai RN Chien R Guan SG Lim CM Lee et al. (2004) ArticleTitleFour years of lamivudine treatment in Chinese patients with chronic hepatitis B J Gastroenterol Hepatol 19 1276–82 Occurrence Handle10.1111/j.1440-1746.2004.03428.x Occurrence Handle1:CAS:528:DC%2BD2cXhtVKnt7vJ Occurrence Handle15482535

    Article  CAS  PubMed  Google Scholar 

  136. AS Lok CL Lai N Leung GB Yao ZY Cui ER Schiff et al. (2003) ArticleTitleLong-term safety of lamivudine treatment in patients with chronic hepatitis B Gastroenterology 125 1714–22 Occurrence Handle10.1053/j.gastro.2003.09.033 Occurrence Handle1:CAS:528:DC%2BD2cXhtVOrug%3D%3D Occurrence Handle14724824

    Article  CAS  PubMed  Google Scholar 

  137. MF Yuen T Kato M Mizokami AO Chan JC Yuen HJ Yuan et al. (2003) ArticleTitleClinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutants J Hepatol 39 850–5 Occurrence Handle10.1016/S0168-8278(03)00388-X Occurrence Handle1:CAS:528:DC%2BD3sXotVert7k%3D Occurrence Handle14568270

    Article  CAS  PubMed  Google Scholar 

  138. F Suzuki Y Suzuki A Tsubota N Akuta T Someya M Kobayashi et al. (2002) ArticleTitleMutations of polymerase, precore and core promoter gene in hepatitis B virus during 5-year lamivudine therapy J Hepatol 37 824–30 Occurrence Handle10.1016/S0168-8278(02)00281-7 Occurrence Handle1:CAS:528:DC%2BD38XoslCjtbo%3D Occurrence Handle12445424

    Article  CAS  PubMed  Google Scholar 

  139. N Akuta F Suzuki M Kobayashi A Tsubota Y Suzuki T Hosaka et al. (2003) ArticleTitleThe influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment J Hepatol 38 315–21 Occurrence Handle1:CAS:528:DC%2BD3sXhtVemtbg%3D Occurrence Handle12586297

    CAS  PubMed  Google Scholar 

  140. T Kirishima T Okanoue Y Daimon Y Itoh H Nakamura A Morita et al. (2002) ArticleTitleDetection of YMDD motif mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment J Hepatol 37 259–65 Occurrence Handle10.1016/S0168-8278(02)00145-9 Occurrence Handle1:CAS:528:DC%2BD38XlsVKjsrY%3D Occurrence Handle12127432

    Article  CAS  PubMed  Google Scholar 

  141. CT Yeh RN Chien CM Chu YF Liaw (2000) ArticleTitleClearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy Hepatology 31 1318–26 Occurrence Handle10.1053/jhep.2000.7296 Occurrence Handle1:CAS:528:DC%2BD3cXkt1Cms7s%3D Occurrence Handle10827158

    Article  CAS  PubMed  Google Scholar 

  142. Mori K, Minami M, Kirishima T, Kunimoto K, Okita M, Nakayama M, et al. Prediction of breakthrough hepatitis due to lamivudine-resistant hepatitis B virus by a sensitive semi-quantitative assay using peptide nucleic acids. Intervirology (in press)

  143. MG Peters HWH Hann P Martin EJ Heathcote P Buggisch R Rubin et al. (2004) ArticleTitleAdefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B Gastroenterology 126 91–101 Occurrence Handle1:CAS:528:DC%2BD2cXhtFGntLo%3D Occurrence Handle14699491

    CAS  PubMed  Google Scholar 

  144. R Perrillo HW Hann D Mutimer B Willems N Leung WM Lee et al. (2004) ArticleTitleAdefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus Gastroenterology 126 81–90 Occurrence Handle10.1053/j.gastro.2003.10.050 Occurrence Handle1:CAS:528:DC%2BD2cXhtFGntL0%3D Occurrence Handle14699490

    Article  CAS  PubMed  Google Scholar 

  145. B Werle-Lapostolle S Bowden S Locarnini K Wursthorn J Petersen G Lau et al. (2004) ArticleTitlePersistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy Gastroenterology 126 1750–8 Occurrence Handle1:CAS:528:DC%2BD2cXlsFaqs78%3D Occurrence Handle15188170

    CAS  PubMed  Google Scholar 

  146. SJ Hadziyannis NC Tassopoulos EJ Heathcote TT Chang G Kitis M Rizzetto et al. (2005) ArticleTitleLong-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B N Engl J Med 352 2673–81 Occurrence Handle10.1056/NEJMoa042957 Occurrence Handle1:CAS:528:DC%2BD2MXls1Sksbc%3D Occurrence Handle15987916

    Article  CAS  PubMed  Google Scholar 

  147. P Angus R Vaughan S Xiong H Yang W Delaney C Gibbs et al. (2003) ArticleTitleResistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase Gastroenterology 125 292–7 Occurrence Handle10.1016/S0016-5085(03)00939-9 Occurrence Handle12891527

    Article  PubMed  Google Scholar 

  148. H Yang X Qi K Das E Arnold CE Westland WE Delaney IV et al. (2004) ArticleTitleIn vitro characterization and molecular modeling analysis of a novel adefovir resistance mutation rtN236T in the HBV polymerase J Hepatol 40 IssueIDSuppl 1 A114

    Google Scholar 

  149. S Hadziyannis N Tassopoulos TT Chang J Heathcote G Kitis M Rizzetto et al. (2004) ArticleTitleThree year study of adfovir dipivoxil (ADV) demonstrates sustained efficacy of in presumed precore mutant chronic hepatitis B patients in a long term safety and efficacy study J Hepatol 40 IssueIDSuppl 1 17

    Google Scholar 

  150. CL Lai M Rosmawati J Lao H Van Vlierberghe FH Anderson N Thomas et al. (2002) ArticleTitleEntecavir is superior to lamivudine in reducing hepatitis B virus DNA in chronic hepatitis B infection Gastroenterology 123 1831–8 Occurrence Handle10.1053/gast.2002.37058 Occurrence Handle1:CAS:528:DC%2BD38Xps1yktbw%3D Occurrence Handle12454840

    Article  CAS  PubMed  Google Scholar 

  151. TT Chang RG Gish SJ Hadziyannis J Cianciara M Rizzetto ER Schiff et al. (2005) ArticleTitleA dose-ranging study of the efficacy and tolerability of entecavir in lamivudine-refractory chronic hepatitis B patients Gastroenterology 129 1198–209 Occurrence Handle10.1053/j.gastro.2005.06.055 Occurrence Handle1:CAS:528:DC%2BD2MXhtFyltb%2FJ Occurrence Handle16230074

    Article  CAS  PubMed  Google Scholar 

  152. RG Gish TT Chang RA De Man A Gadano J Sollano KH Han et al. (2005) ArticleTitleEntecavir results in substantial virologic and biochemical improvement and HBeAg seroconversion through 96 weeks of treatment in HBeAg(+) chronic hepatitis B patients (study ETV-022) Hepatology 42 IssueIDSuppl 1 267A

    Google Scholar 

  153. SW Schalm J Heathcote J Cianciara G Farrell M Sherman B Willems et al. (2000) ArticleTitleLamivudine and alpha interferon combination therapy of patients with chronic hepatitis B infection: a randomized trial Gut 46 562–8 Occurrence Handle10.1136/gut.46.4.562 Occurrence Handle1:CAS:528:DC%2BD3cXis1ems7Y%3D Occurrence Handle10716688

    Article  CAS  PubMed  Google Scholar 

  154. G Barbaro F Zechini AM Pellicelli R Francavilla G Scotto D Bacca et al. (1998) ArticleTitleLong-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B: an Italian multicenter, randomized trial J Hepatol 28 923–9 Occurrence Handle10.1016/S0168-8278(98)81058-1

    Article  Google Scholar 

  155. I Tatulli R Francavilla GL Rizzo V Vinciguerra E Ierardi A Amoruso et al. (2001) ArticleTitleLamivudine and alpha-interferon in combination long term for precore mutant chronic hepatitis B J Hepatol 35 805–10 Occurrence Handle10.1016/S0168-8278(01)00201-X Occurrence Handle1:CAS:528:DC%2BD38XmtVCmsA%3D%3D Occurrence Handle11738109

    Article  CAS  PubMed  Google Scholar 

  156. T Santantonio GA Niro E Sinisi G Leandro M Insalata A Guastadisegni et al. (2002) ArticleTitleLamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: a controlled pilot study J Hepatol 36 799–804 Occurrence Handle1:CAS:528:DC%2BD38XktVCktLg%3D Occurrence Handle12044531

    CAS  PubMed  Google Scholar 

  157. ER Schiff JL Dienstag S Karayalcin IS Grimm RP Perrillo P Husa et al. (2003) ArticleTitleLamivudine and 24 weeks lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders J Hepatol 38 818–26 Occurrence Handle1:CAS:528:DC%2BD3sXjvFWnsLs%3D Occurrence Handle12763376

    CAS  PubMed  Google Scholar 

  158. US Akarca G Ersoz F Gunsar Z Karasu E Saritas G Yuce et al. (2004) ArticleTitleInterferon-lamivudine combination is no better than lamivudine alone in anti-HBe-positive chronic hepatitis B Antivir Ther 9 325–34 Occurrence Handle1:CAS:528:DC%2BD2cXntVagu7k%3D Occurrence Handle15259895

    CAS  PubMed  Google Scholar 

  159. VA Sypsa K Mimidis NC Tassopoulos D Chrysagis T Vassiliadis A Moulakakis et al. (2005) ArticleTitleA viral kinetic study using pegylated interferon alfa-2b and /or lamivudine in patients with chronic hepatitis B/HBeAg negative Hepatology 42 77–85 Occurrence Handle10.1002/hep.20738 Occurrence Handle1:CAS:528:DC%2BD2MXms12nsbY%3D Occurrence Handle15962284

    Article  CAS  PubMed  Google Scholar 

  160. HL Chan AY Hui VW Wong AM Chim ML Wong JJ Sung (2005) ArticleTitleLong-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B Hepatology 41 1357–64 Occurrence Handle1:CAS:528:DC%2BD2MXlvVSnu7c%3D Occurrence Handle15880608

    CAS  PubMed  Google Scholar 

  161. CL Lai N Leung EK Teo M Tong F Wong HW Hann et al. (2005) ArticleTitleA 1-year trial of telbivudine, lamivudine, and combination in patients with hepatitis B e antigen-positive chronic hepatitis Gastroenterology 129 528–36 Occurrence Handle1:CAS:528:DC%2BD2MXpvVWmsLs%3D Occurrence Handle16083710

    CAS  PubMed  Google Scholar 

  162. HS Lee YH Chung KS Lee KS Byun SW Paik JY Han et al. (2004) ArticleTitleA 12-week clevudine therapy showed durable antiviral activity and normalization of alanine transaminase levels for 6 months after discontinuation of treatment in patients with chronic hepatitis B Hepatology 40 IssueIDSuppl 1 652A

    Google Scholar 

  163. F Van Bommel T Wunsche S Mauss P Reinke A Bergk D Schurmann et al. (2004) ArticleTitleComparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection Hepatology 40 1421–5 Occurrence Handle15565615

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Hirokoji, Kawaramachi, Kamigyo-ku, Kyoto, 602-8566, Japan

    Takeshi Okanoue & Masahito Minami

Authors
  1. Takeshi Okanoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masahito Minami
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Okanoue, T., Minami, M. Update of research and management of hepatitis B. J Gastroenterol 41, 107–118 (2006). https://doi.org/10.1007/s00535-006-1774-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-006-1774-5

Key words

Search

Navigation